Merck Research Labs president presents at Citi 2016 conference

American Pharmacy News Reports | Dec 11, 2016
Dr. Roger Perlmutter participated in the Citi 2016 Global Healthcare Conference.
Dr. Roger Perlmutter participated in the Citi 2016 Global Healthcare Conference. | Contributed photo
Merck Research Laboratories President Dr. Roger Perlmutter participated in the Citi 2016 Global Healthcare Conference Wednesday in New York.
Perlmutter’s presentation was broadcast through Merck’s investor website as a webcast.
The company invited investors, analysts and members of the media to listen in live.

More News

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

People CDC releases COVID-19 guidance for those with health conditions Jan 10, 2021

Novavax is the latest COVID-19 vaccine to enter Phase III clinical trials.

Innovation Fifth vaccine set to enter Phase III clinical trials Jan 3, 2021

Regulatory CENTENE: Completes Acquisition of PANTHERx Rare Pharmacy (PANTHERx) Dec 31, 2020

Industry NHA: Creates Partnership, Path for Accredited Immunization Training for Pharmacy Technicians Ahead of New Vaccines Dec 31, 2020

Industry TRANQUILMONEY: Releases PharmTracker for Independent Pharmacies, Small and Medium Pharmacy Chains Dec 26, 2020

Industry MITSUBISHI TANABE PHARMA AMERICA: Announces Initiation of Open-Label Extension Study of Oral Edaravone in ALS Dec 22, 2020

Trending

Those with preexisting health conditions may experience a different immune response to the COVID-19 vaccination.

CDC releases COVID-19 guidance for those with health conditions